Rigel is a biotechnology company that develops drugs for cancer and hematologic disorders.
Business Model:
Revenue: $89.4M
Employees: 51-200
Address: 1180 Veterans Boulevard
City: South San Francisco
State: CA
Zip: 94080
Country: US
Rigel is a biotechnology company that develops drugs for cancer and hematologic disorders.
Contact Phone:
+16506241100
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
12/8/2000
Ticker Symbol:
RIGL
IPO Price:
$7/share
Amount Raised:
$35M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2010 | Post-IPO Equity | 1 | - |
New Enterprise Associates New Enterprise Associates |
1/2021 | Grant | 1 | $16.5M |
U.S. Department of Defense U.S. Department of Defense |
5/2011 | Post-IPO Equity | $130M | 11/2000 | IPO | $35M | 4/2003 | Post-IPO Equity | 4 | $46M |
Alta Partners Frazier Healthcare Partners MPM Capital HBM Healthcare Investments AG MPM Capital Alta Partners Frazier Healthcare Partners MPM Capital HBM Healthcare Investments AG MPM Capital |
10/2019 | Debt | $10M |
MidCap Financial |
1/2010 | Post-IPO Equity | 1 | - |
New Enterprise Associates New Enterprise Associates |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|